|
CN111559980A
|
|
Ornidazole isomer and preparation method thereof
|
|
CN111337619A
|
|
Method for analyzing ibandronate sodium drug by ion chromatography
|
|
CN111007168A
|
|
Method for analyzing adefovir dipivoxil N3-isomer by ultra-high performance liquid chromatography
|
|
CN110872242A
|
|
Synthesis method of celecoxib intermediate p-hydrazino benzenesulfonamide hydrochloride
|
|
CN110407683A
|
|
A kind of preparation method of celecoxib diketone intermediate
|
|
CN109912531A
|
|
The preparation method of high-purity Febustat
|
|
CN109438514A
|
|
The preparation method of Aldoforwe ester
|
|
CN107828811A
|
|
Plasmid standard, its preparation method and its application of the target gene of thymalfasin containing people
|
|
CN107474000A
|
|
The preparation method of Ezetimibe degradation impurity
|
|
CN107162996A
|
|
A kind of preparation method of high-purity Nifuratel intermediate
|
|
CN106361829A
|
|
Traditional Chinese medicine composition for treating ischemic stroke, preparation and preparation method thereof
|
|
CN105541750A
|
|
Method for preparing Myrbetriq analysis comparison product
|
|
CN104961674A
|
|
Preparation method of reference substance for synthesizing etoricoxib
|
|
CN104922090A
|
|
Mesalazine enteric-coated sustained-release pellet and preparation method thereof
|
|
CN103923101A
|
|
Synthetic method of prasugrel
|
|
CN103919905A
|
|
Medicine composition as well as preparation method and application of medicine composition in preparation of medicines for treating osteoporosis
|
|
CN103755657A
|
|
Preparation method of rivaroxaban intermediate
|
|
CN103664923A
|
|
Preparation method for nifuratel
|
|
CN103641774A
|
|
Preparation method of benidipine hydrochloride
|
|
CN102558056A
|
|
Celecoxib and preparing method thereof
|
